PARLIAMENTARY WRITTEN QUESTION
HIV Infection: Drugs (13 June 2018)

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 26 April 2018 to question 136402 on HIV Infection: Drugs, if he will he make an assessment of the potential barriers to joining the PrEP Impact trial for women who are victims of domestic violence.

Asked by:
Sarah Champion (Labour)

The HIV pre-exposure prophylaxis (PrEP) Impact Trial Team works together with the Trial Community Advisory Board to address issues regarding barriers to recruitment. A number of workstreams are ongoing or planned to specifically address access to the trial by women. These include a review of risk factors and associated vulnerabilities among women recruited to the trial; interviews with women to explore the facilitators and barriers to accessing PrEP; and mapping of activities across the country relating to PrEP awareness-raising among key populations including women.

Through Public Health England’s HIV Prevention Innovation Fund, three PrEP initiatives have been funded that aim to raise awareness in underserved communities, including women.

Answered by:
Steve Brine (Conservative)
21 June 2018